ABSI Average Annual Return Since 2021
Growth of $10,000.00
Without Dividends Reinvested Into ABSI


Also see:
ABSI stock yearly return 2022
ABSI stock yearly return 2023
ABSI stock yearly return 2024
ABSI YTD return
Compare ABSI average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return
Start date: 07/23/2021
End date: 01/17/2025
Start price/share: $22.89
End price/share: $2.90
Dividends collected/share: $0.00
Total return: -87.33%
ABSI Average Annual Return: -44.67%
Starting investment: $10,000.00
Ending investment: $1,267.15
Years: 3.49


ABSI average annual return is presented with the assumption of reinvestments of any dividends on ex-date.
Absci Corporation is a generative artificial intelligence (AI) drug creation company. Co. combines AI with scalable wet lab technologies to create biologics for patients. It has built an Integrated Drug Creation platform to identify novel drug targets, discover biotherapeutic candidates, and generate the cell lines to manufacture them in a single process. Co. uses its platform to predict, identify, design, construct, screen, select and scale production of biologic drug candidates for its partners, and learn from the data it generates. Its SoluPro technology is a multiplex synthetic biology approach that overcomes the limitations of highest-throughput automation labs. The ABSI average annual return since 2021 is shown above.

The Average Annual Return on the ABSI average annual return since 2021 page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends.

Thus, researching Average Annual Returns is good practice for investors — whether ABSI average annual return since 2021 or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the ABSI average annual return calculation with any dividends reinvested as applicable (on ex-dates).
Quotes delayed 20 minutes

Email EnvelopeFree ABSI Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Don't Forget Dividends in Average Annual Return!


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Absci (ABSI) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

ABT Average Annual Return
ABVC Average Annual Return
ACAD Average Annual Return
ACCD Average Annual Return
ACET Average Annual Return
ACHC Average Annual Return
ACHV Average Annual Return
ACLX Average Annual Return
ACON Average Annual Return
ACRS Average Annual Return
More Healthcare companies »

 

ABSI Average Annual Return Since 2021 | www.AverageAnnualReturn.com | Copyright © 2021 - 2025, All Rights Reserved

Nothing in AverageAnnualReturn.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.